CC - Chemours Co Stock Price, News & Analysis

$52.86 -0.11 (-0.21 %)
(As of 11/24/2017 02:44 AM ET)
Previous Close$52.97
Today's Range$53.42 - $52.49
52-Week Range$20.76 - $58.08
Volume1.26 million shs
Average Volume2.72 million shs
Market Capitalization$9.81 billion
P/E Ratio18.78
Dividend Yield0.23%
Beta3.59

About Chemours Co (NYSE:CC)

Chemours Co logoThe Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins. The Chemical Solutions segment is a North American provider of industrial chemicals used in gold production, oil and gas, water treatment and other industries. It delivers customized solutions with a range of industrial and specialty chemical products for markets, including plastics and coatings, refrigeration and air conditioning, industrial, mining and oil refining. Its products include titanium dioxide, refrigerants, industrial fluoropolymer resins and a portfolio of mining and industrial chemicals, including sodium cyanide. As of December 31, 2016, the Company operates 26 production facilities located in 10 countries.


Industry, Sector and Symbol

Industry Commodity Chemicals
Sub-IndustryN/A
SectorBasic Materials
SymbolNYSE:CC
CUSIPN/A

Debt

Debt-to-Equity Ratio5.07%
Current Ratio2.19%
Quick Ratio1.63%

Price-To-Earnings

Trailing P/E Ratio18.78
Forward P/E Ratio14.17
P/E Growth0.92

Sales & Book Value

Annual Sales$5.40 billion
Price / Sales1.81
Cash Flow$2.69 per share
Price / Cash19.62
Book Value$4.35 per share
Price / Book12.15

Dividend

Annual Dividend$0.12
Dividend Yield0.2%

Profitability

Trailing EPS$1.45
Net Income$7 million
Net Margins4.86%
Return on Equity116.80%
Return on Assets8.10%

Miscellaneous

Employees7,000
Outstanding Shares185,160,000

Frequently Asked Questions for Chemours Co (NYSE:CC)

What is Chemours Co's stock symbol?

Chemours Co trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

How often does Chemours Co pay dividends? What is the dividend yield for Chemours Co?

Chemours Co announced a quarterly dividend on Tuesday, November 7th. Shareholders of record on Monday, November 20th will be paid a dividend of $0.03 per share on Friday, December 15th. This represents a $0.12 dividend on an annualized basis and a yield of 0.23%. The ex-dividend date is Friday, November 17th. View Chemours Co's Dividend History.

How were Chemours Co's earnings last quarter?

Chemours Co (NYSE:CC) posted its quarterly earnings data on Thursday, November, 2nd. The specialty chemicals company reported $1.12 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.01 by $0.11. The specialty chemicals company earned $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. Chemours Co had a net margin of 4.86% and a return on equity of 116.80%. The business's revenue for the quarter was up 13.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.61 earnings per share. View Chemours Co's Earnings History.

When will Chemours Co make its next earnings announcement?

Chemours Co is scheduled to release their next quarterly earnings announcement on Tuesday, February, 13th 2018. View Earnings Estimates for Chemours Co.

Where is Chemours Co's stock going? Where will Chemours Co's stock price be in 2017?

7 equities research analysts have issued twelve-month price targets for Chemours Co's stock. Their forecasts range from $27.00 to $60.00. On average, they expect Chemours Co's share price to reach $52.71 in the next year. View Analyst Ratings for Chemours Co.

What are Wall Street analysts saying about Chemours Co stock?

Here are some recent quotes from research analysts about Chemours Co stock:

  • 1. According to Zacks Investment Research, "Chemours Company is involved in chemical business. It operating segment consists of Titanium Technologies, Fluoroproducts and Chemical Solutions. Titanium Technologies segment produces titanium dioxide and premium white pigment. Fluoroproducts segment provides fluoroproducts, refrigerants and industrial fluoropolymer resins. Chemical Solutions segment provides industrial and specialty chemicals. The company's brand consists of Teflon(R), Ti-Pure(R), Krytox(R) Viton(R), Opteon(R) and Nafion(R). Chemours Company is headquartered in Wilmington. " (11/9/2017)
  • 2. Jefferies Group LLC analysts commented, "Clarity on the PFOA liability significantly reduces Chemours' risk profile, and the stock has responded accordingly. In our view, the next 18 months are a story of delivering on cost controls, leveraging and extending Opteon, and managing TiO2 as the industry shifts from a restock cycle to a potential improvement in underlying demand." (2/15/2017)

Who are some of Chemours Co's key competitors?

Who are Chemours Co's key executives?

Chemours Co's management team includes the folowing people:

  • Richard H. Brown, Independent Chairman of the Board (Age 69)
  • Mark P. Vergnano, President, Chief Executive Officer, Director (Age 59)
  • Mark E. Newman, Chief Financial Officer, Senior Vice President (Age 53)
  • Paul Kirsch, President - Fluoroproducts (Age 53)
  • Christian W. Siemer, President - Chemical Solutions (Age 58)
  • E. Bryan Snell, President - Titanium Technologies (Age 60)
  • Elizabeth Albright, Senior Vice President - Human Resources (Age 50)
  • Erich Parker, Vice President of Corporate Communications, Chief Brand Officer (Age 65)
  • David Charles Shelton, Corporate Secretary and General Counsel (Age 53)
  • Curtis V. Anastasio, Independent Director (Age 60)

Who owns Chemours Co stock?

Chemours Co's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Prudential Financial Inc. (2.16%), Allianz Asset Management GmbH (1.44%), Bank of New York Mellon Corp (1.28%), JPMorgan Chase & Co. (1.19%), Greenlight Capital Inc. (0.80%) and Columbus Circle Investors (0.55%). Company insiders that own Chemours Co stock include Amy Trojanowski, Bradley J Bell, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman, Paul Kirsch, Richard H Brown and Stephen D Newlin. View Institutional Ownership Trends for Chemours Co.

Who sold Chemours Co stock? Who is selling Chemours Co stock?

Chemours Co's stock was sold by a variety of institutional investors in the last quarter, including Greenlight Capital Inc., Prudential Financial Inc., Allianz Asset Management GmbH, BNP Paribas Arbitrage SA, Private Management Group Inc., Fuller & Thaler Asset Management Inc., ING Groep NV and California Public Employees Retirement System. Company insiders that have sold Chemours Co company stock in the last year include Amy Trojanowski, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman and Paul Kirsch. View Insider Buying and Selling for Chemours Co.

Who bought Chemours Co stock? Who is buying Chemours Co stock?

Chemours Co's stock was acquired by a variety of institutional investors in the last quarter, including Ardevora Asset Management LLP, Capital Growth Management LP, Columbus Circle Investors, Los Angeles Capital Management & Equity Research Inc., Janus Henderson Group PLC, Neuberger Berman Group LLC, Victory Capital Management Inc. and Assenagon Asset Management S.A.. Company insiders that have bought Chemours Co stock in the last two years include Bradley J Bell, Mark Newman, Richard H Brown and Stephen D Newlin. View Insider Buying and Selling for Chemours Co.

How do I buy Chemours Co stock?

Shares of Chemours Co can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Chemours Co's stock price today?

One share of Chemours Co stock can currently be purchased for approximately $52.86.

How big of a company is Chemours Co?

Chemours Co has a market capitalization of $9.81 billion and generates $5.40 billion in revenue each year. The specialty chemicals company earns $7 million in net income (profit) each year or $1.45 on an earnings per share basis. Chemours Co employs 7,000 workers across the globe.

How can I contact Chemours Co?

Chemours Co's mailing address is 1007 MARKET STREET, WILMINGTON DE, 19899. The specialty chemicals company can be reached via phone at 302-773-1000 or via email at [email protected]


MarketBeat Community Rating for Chemours Co (CC)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  148 (Vote Outperform)
Underperform Votes:  181 (Vote Underperform)
Total Votes:  329
MarketBeat's community ratings are surveys of what our community members think about Chemours Co and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Chemours Co (NYSE:CC)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 7 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $52.71 (0.28% downside)

Consensus Price Target History for Chemours Co (NYSE:CC)

Price Target History for Chemours Co (NYSE:CC)

Analysts' Ratings History for Chemours Co (NYSE:CC)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/6/2017Barclays PLCBoost Price TargetOverweight$55.00 -> $58.00N/AView Rating Details
8/10/2017ArgusReiterated RatingBuy$50.00 -> $55.00HighView Rating Details
8/4/2017J P Morgan Chase & CoBoost Price TargetOverweight$55.00LowView Rating Details
8/4/2017Citigroup Inc.Boost Price TargetBuy$45.00 -> $59.00HighView Rating Details
8/3/2017Jefferies Group LLCBoost Price TargetBuy$60.00HighView Rating Details
5/15/2017Susquehanna Bancshares IncBoost Price TargetPositive$45.00 -> $55.00LowView Rating Details
2/13/2017Goldman Sachs Group IncUpgradeNeutral -> BuyN/AView Rating Details
(Data available from 11/24/2015 forward)

Earnings

Earnings History and Estimates Chart for Chemours Co (NYSE:CC)

Earnings by Quarter for Chemours Co (NYSE:CC)

Earnings History by Quarter for Chemours Co (NYSE CC)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/13/2018$0.97N/AView Earnings Details
11/2/2017Q3 2017$1.01$1.12$1.59 billion$1.58 billionViewN/AView Earnings Details
8/2/2017Q2 2017$0.85$0.87$1.49 billion$1.59 billionViewListenView Earnings Details
5/1/2017Q1 2017$0.50$0.75$1.32 billion$1.44 billionViewListenView Earnings Details
2/15/2017Q416$0.29$0.08$1.24 billion$1.30 billionViewN/AView Earnings Details
11/6/2016Q3 2016$0.25$0.61$1.29 billion$1.40 billionViewN/AView Earnings Details
8/8/2016Q216$0.17$0.27$1.42 billion$1.38 billionViewN/AView Earnings Details
5/2/2016Q116$0.02$0.06$1.27 billion$1.30 billionViewN/AView Earnings Details
2/23/2016Q415$0.09$0.03$1.36 billion$1.40 billionViewListenView Earnings Details
11/5/2015Q315$0.26$0.40$1.52 billion$1.49 billionViewN/AView Earnings Details
8/6/2015Q215$0.33$0.24$1.53 billion$1.50 billionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Chemours Co (NYSE:CC)
2017 EPS Consensus Estimate: $3.38
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.51$0.51$0.51
Q2 20171$0.94$0.94$0.94
Q3 20171$0.97$0.97$0.97
Q4 20171$0.96$0.96$0.96
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Chemours Co (NYSE:CC)

Next Dividend:12/15/2017
Annual Dividend:$0.12
Dividend Yield:0.23%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:8.28% (Trailing 12 Months of Earnings)
3.22% (Based on This Year's Estimates)
2.34% (Based on Next Year's Estimates)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Chemours Co (NYSE:CC)

Dividend History by Quarter for Chemours Co (NYSE CC)

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/7/2017quarterly$0.030.24%11/17/201711/20/201712/15/2017
8/2/2017quarterly$0.030.25%8/15/20178/17/20179/15/2017
4/27/2017quarterly$0.030.3%5/15/20175/17/20176/15/2017
2/14/2017quarterly$0.030.37%2/23/20172/27/20173/15/2017
11/2/2016quarterly$0.030.72%11/15/201611/17/201612/15/2016
8/3/2016quarterly$0.031.34%8/15/20168/17/20169/15/2016
4/27/2016quarterly$0.031.27%5/13/20165/17/20166/15/2016
2/23/2016quarterly$0.032.44%3/9/20163/11/20163/31/2016
9/1/2015quarterly$0.031.38%11/10/201511/13/201512/14/2015
7/24/2015special$0.557/30/20158/3/20159/11/2015
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Chemours Co (NYSE CC)

Insider Ownership Percentage: 1.14%
Institutional Ownership Percentage: 74.04%
Insider Trades by Quarter for Chemours Co (NYSE:CC)
Institutional Ownership by Quarter for Chemours Co (NYSE:CC)

Insider Trades by Quarter for Chemours Co (NYSE CC)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/6/2017E Bryan SnellInsiderSell11,878$53.25$632,503.50View SEC Filing  
10/13/2017David C SheltonSVPSell5,908$56.01$330,907.08View SEC Filing  
10/10/2017David C SheltonSVPSell13,397$55.00$736,835.00View SEC Filing  
10/5/2017David C SheltonSVPSell19,000$53.68$1,019,920.00View SEC Filing  
9/5/2017E Bryan SnellInsiderSell13,000$49.35$641,550.00View SEC Filing  
8/31/2017David C. SheltonSVPSell13,337$48.48$646,577.76View SEC Filing  
8/11/2017Amy TrojanowskiVPSell2,500$46.03$115,075.00View SEC Filing  
8/11/2017E Bryan SnellInsiderSell10,000$46.24$462,400.00View SEC Filing  
6/5/2017Paul KirschInsiderSell19,036$41.42$788,471.12View SEC Filing  
5/16/2017Erich ParkerVPSell4,908$45.53$223,461.24View SEC Filing  
5/5/2017Mark NewmanVPSell22,781$39.83$907,367.23View SEC Filing  
5/3/2017Richard H. BrownDirectorBuy2,500$39.10$97,750.00View SEC Filing  
5/13/2016Mark NewmanCFOBuy2,800$9.71$27,188.00View SEC Filing  
5/4/2016Bradley J BellDirectorBuy10,000$9.65$96,500.00View SEC Filing  
2/26/2016Stephen D. NewlinDirectorBuy10,000$4.94$49,400.00View SEC Filing  
11/23/2015Thierry Fj VanlanckerInsiderBuy15,000$6.00$90,000.00View SEC Filing  
9/14/2015E Bryan SnellInsiderBuy8,000$8.89$71,120.00View SEC Filing  
9/11/2015Amy TrojanowskiVPBuy5,400$9.24$49,896.00View SEC Filing  
9/10/2015Christian W SiemerInsiderBuy10,100$9.39$94,839.00View SEC Filing  
9/9/2015Mark NewmanCFOBuy10,600$9.32$98,792.00View SEC Filing  
9/8/2015Christian W SiemerInsiderBuy11,000$9.11$100,210.00View SEC Filing  
9/4/2015David C SheltonSVPBuy5,000$9.00$45,000.00View SEC Filing  
9/4/2015Mark P VergnanoCEOBuy72,600$9.25$671,550.00View SEC Filing  
9/4/2015Stephen D. NewlinDirectorBuy7,000$9.18$64,260.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Chemours Co (NYSE CC)

Source:
DateHeadline
Chemours Company (The) (CC) versus Its Rivals Head to Head AnalysisChemours Company (The) (CC) versus Its Rivals Head to Head Analysis
www.americanbankingnews.com - November 22 at 9:04 PM
Top Ranked Growth Stocks to Buy for November 21stTop Ranked Growth Stocks to Buy for November 21st
finance.yahoo.com - November 21 at 5:13 PM
The Chemours Co. : CC-US: Dividend Analysis : November 20th, 2017 (record date) : By the numbers : November 20, 2017The Chemours Co. : CC-US: Dividend Analysis : November 20th, 2017 (record date) : By the numbers : November 20, 2017
finance.yahoo.com - November 20 at 6:09 PM
Reviewing PQ Group Holdings (PQG) and Chemours Company (The) (CC)Reviewing PQ Group Holdings (PQG) and Chemours Company (The) (CC)
www.americanbankingnews.com - November 19 at 1:16 PM
North Carolina regulator revokes Chemours process wastewater permit - Seeking AlphaNorth Carolina regulator revokes Chemours' process wastewater permit - Seeking Alpha
seekingalpha.com - November 18 at 8:37 AM
Chemours Company (CC) Ex-Dividend Date Scheduled for November 17, 2017 - NasdaqChemours Company (CC) Ex-Dividend Date Scheduled for November 17, 2017 - Nasdaq
www.nasdaq.com - November 16 at 3:22 PM
Top Ranked Growth Stocks to Buy for November 15thTop Ranked Growth Stocks to Buy for November 15th
finance.yahoo.com - November 16 at 12:30 PM
FY2017 EPS Estimates for Chemours Company (The) Boosted by Analyst (CC)FY2017 EPS Estimates for Chemours Company (The) Boosted by Analyst (CC)
www.americanbankingnews.com - November 15 at 6:58 AM
Zacks.com highlights: Chemours, POSCO, Ecopetrol S.A. and Micron TechnologyZacks.com highlights: Chemours, POSCO, Ecopetrol S.A. and Micron Technology
finance.yahoo.com - November 14 at 5:28 PM
FY2018 Earnings Estimate for Chemours Company (The) (CC) Issued By Jefferies GroupFY2018 Earnings Estimate for Chemours Company (The) (CC) Issued By Jefferies Group
www.americanbankingnews.com - November 14 at 12:12 PM
Chemours Company (The) (CC) & Its Competitors Head-To-Head ContrastChemours Company (The) (CC) & Its Competitors Head-To-Head Contrast
www.americanbankingnews.com - November 14 at 1:32 AM
Chemours to Pay a 4Q17 DividendChemours to Pay a 4Q17 Dividend
finance.yahoo.com - November 13 at 11:24 PM
Head-To-Head Analysis: Chemours Company (The) (CC) & Methanex Corporation (MEOH)Head-To-Head Analysis: Chemours Company (The) (CC) & Methanex Corporation (MEOH)
www.americanbankingnews.com - November 13 at 5:15 AM
Earnings Review and Free Research Report: Kraton’s Adjusted EPS soared 139.6%Earnings Review and Free Research Report: Kraton’s Adjusted EPS soared 139.6%
finance.yahoo.com - November 10 at 10:21 AM
Chemours Company (The) (CC) Upgraded to "Buy" at Zacks Investment ResearchChemours Company (The) (CC) Upgraded to "Buy" at Zacks Investment Research
www.americanbankingnews.com - November 9 at 6:28 PM
E Bryan Snell Sells 11,878 Shares of Chemours Company (The) (CC) StockE Bryan Snell Sells 11,878 Shares of Chemours Company (The) (CC) Stock
www.americanbankingnews.com - November 9 at 12:32 AM
The Chemours Co. breached its 50 day moving average in a Bearish Manner : CC-US : November 8, 2017The Chemours Co. breached its 50 day moving average in a Bearish Manner : CC-US : November 8, 2017
finance.yahoo.com - November 8 at 8:03 PM
The Chemours Co. – Value Analysis (NYSE:CC) : November 7, 2017The Chemours Co. – Value Analysis (NYSE:CC) : November 7, 2017
finance.yahoo.com - November 7 at 8:00 PM
Chemours Announces Fourth Quarter DividendChemours Announces Fourth Quarter Dividend
finance.yahoo.com - November 7 at 8:00 PM
Chemours Company (The) to Issue Quarterly Dividend of $0.03 (CC)Chemours Company (The) to Issue Quarterly Dividend of $0.03 (CC)
www.americanbankingnews.com - November 7 at 6:26 PM
Chemours Company (The) (CC) PT Raised to $58.00Chemours Company (The) (CC) PT Raised to $58.00
www.americanbankingnews.com - November 6 at 9:43 PM
Chemours posts 3Q profitChemours posts 3Q profit
finance.yahoo.com - November 6 at 6:09 PM
The Chemours Co. breached its 50 day moving average in a Bearish Manner : CC-US : November 6, 2017The Chemours Co. breached its 50 day moving average in a Bearish Manner : CC-US : November 6, 2017
finance.yahoo.com - November 6 at 6:09 PM
Chemours Company (The) (CC) Receives Consensus Recommendation of "Buy" from AnalystsChemours Company (The) (CC) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - November 6 at 3:58 PM
Heres Why Chemours Co. Dropped as Much as 12.1% Today - Motley FoolHere's Why Chemours Co. Dropped as Much as 12.1% Today - Motley Fool
www.fool.com - November 5 at 4:58 AM
Chemours Company (The) (CC) Price Target Increased to $59.00 by Analysts at UBS Group AG (USA)Chemours Company (The) (CC) Price Target Increased to $59.00 by Analysts at UBS Group AG (USA)
www.americanbankingnews.com - November 4 at 6:06 PM
The Chemours (CC) CEO Mark Vergnano on Q3 2017 Results - Earnings Call TranscriptThe Chemours' (CC) CEO Mark Vergnano on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 4 at 3:48 AM
Edited Transcript of CC earnings conference call or presentation 3-Nov-17 12:30pm GMTEdited Transcript of CC earnings conference call or presentation 3-Nov-17 12:30pm GMT
finance.yahoo.com - November 3 at 10:45 PM
[$$] How a DuPont Carve-Out Made a Comeback[$$] How a DuPont Carve-Out Made a Comeback
finance.yahoo.com - November 3 at 5:43 PM
Here's Why Chemours Co. Dropped as Much as 12.1% TodayHere's Why Chemours Co. Dropped as Much as 12.1% Today
finance.yahoo.com - November 3 at 5:43 PM
The Chemours Company Q3 Earnings Rise 91% - NasdaqThe Chemours Company Q3 Earnings Rise 91% - Nasdaq
www.nasdaq.com - November 3 at 8:02 AM
The Chemours Company Reports Third Quarter Results - PR Newswire (press release)The Chemours Company Reports Third Quarter Results - PR Newswire (press release)
www.prnewswire.com - November 3 at 8:02 AM
Chemours Co. to Host Earnings CallChemours Co. to Host Earnings Call
finance.yahoo.com - November 3 at 8:02 AM
Chemours Company (The) (CC) Issues Quarterly  Earnings Results, Beats Estimates By $0.17 EPSChemours Company (The) (CC) Issues Quarterly Earnings Results, Beats Estimates By $0.17 EPS
www.americanbankingnews.com - November 2 at 8:44 PM
The Chemours Company Q3 Earnings Rise 91%The Chemours Company Q3 Earnings Rise 91%
www.rttnews.com - November 2 at 5:47 PM
The Chemours Company Q3 Earnings Rise 91%The Chemours Company Q3 Earnings Rise 91%
www.rttnews.com - November 2 at 5:47 PM
At $56.97, Is The Chemours Company (CC) A Sell?At $56.97, Is The Chemours Company (CC) A Sell?
finance.yahoo.com - November 2 at 5:47 PM
At $56.97, Is The Chemours Company (CC) A Sell?At $56.97, Is The Chemours Company (CC) A Sell?
finance.yahoo.com - November 2 at 5:47 PM
The Chemours Company Reports Third Quarter ResultsThe Chemours Company Reports Third Quarter Results
finance.yahoo.com - November 2 at 5:47 PM
The Chemours Company Reports Third Quarter ResultsThe Chemours Company Reports Third Quarter Results
finance.yahoo.com - November 2 at 5:47 PM
Chemours shares down 3% after third-quarter earningsChemours shares down 3% after third-quarter earnings
finance.yahoo.com - November 2 at 5:47 PM
Chemours shares down 3% after third-quarter earningsChemours shares down 3% after third-quarter earnings
finance.yahoo.com - November 2 at 5:47 PM
Chemours Company (The) (CC) versus PQ Group Holdings (PQG) Head to Head AnalysisChemours Company (The) (CC) versus PQ Group Holdings (PQG) Head to Head Analysis
www.americanbankingnews.com - November 2 at 5:30 AM
Key Predictions for Q3 Earnings Reports of DWDP, CC, PAHKey Predictions for Q3 Earnings Reports of DWDP, CC, PAH
www.nasdaq.com - November 1 at 5:44 PM
Contrasting Chemours Company (The) (CC) and Its RivalsContrasting Chemours Company (The) (CC) and Its Rivals
www.americanbankingnews.com - November 1 at 5:06 AM
Financial Contrast: Chemours Company (The) (CC) and NewMarket Corporation (NEU)Financial Contrast: Chemours Company (The) (CC) and NewMarket Corporation (NEU)
www.americanbankingnews.com - October 31 at 7:18 PM
Chemours Announces Plan to Build Innovation Center at University of Delawares Science Technology and Advanced Research CampusChemours Announces Plan to Build Innovation Center at University of Delaware's Science Technology and Advanced Research Campus
finance.yahoo.com - October 30 at 6:06 PM
Chemours Company (The) (CC) to Release Earnings on ThursdayChemours Company (The) (CC) to Release Earnings on Thursday
www.americanbankingnews.com - October 26 at 1:46 AM
Chemours Company (The) (CC) & Its Competitors Head-To-Head SurveyChemours Company (The) (CC) & Its Competitors Head-To-Head Survey
www.americanbankingnews.com - October 24 at 4:38 PM
Comparing Enzymotec (ENZY) & Chemours Company (The) (CC)Comparing Enzymotec (ENZY) & Chemours Company (The) (CC)
www.americanbankingnews.com - October 24 at 2:14 PM

Social Media

Financials

Chart

Chemours Co (NYSE CC) Chart for Friday, November, 24, 2017
Loading chart…

This page was last updated on 11/24/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.